| Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. | |
| | |
MedLine Citation:
|
PMID: 7533615 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
1. The present investigation compares the effects of intravenous infusion of the NO synthase inhibitor NG-monomethyl-L-arginine (L-NMMA) with that of an inhalation with NO gas in a porcine model of endotoxin (lipopolysaccharide, LPS) shock. In addition, the effects of the combination of these two treatments were also investigated. 2. Male pigs were anaesthetized and instrumented for the measurement of haemodynamic parameters. Blood samples were withdrawn at different time intervals for determination of blood gases, pH, and plasma levels of nitrite/nitrate and tumour necrosis factor. 3. Endotoxin infusion (15 micrograms kg-1 h-1 for 3 h) caused a progressive fall in mean arterial blood pressure (MABP) and cardiac output (CO) and a biphasic increase in mean pulmonary arterial pressure (MPAP) and pulmonary vascular resistance (PVR). A continuous infusion of L-NMMA (0.1 mg kg-1 min-1) significantly attenuated the fall in MABP, but did not affect MPAP, CO and PVR. NO-inhalation (50 p.p.m.) did not affect MABP, but significantly blunted the biphasic increase in MPAP and PVR and significantly delayed the fall in CO. The combination of L-NMMA infusion (0.1 mg kg-1 min-1) with NO-inhalation (50 p.p.m.) completely prevented the fall in MABP, significantly improved CO, and attenuated the biphasic increase in MPAP and PVR. 4. Endotoxin also caused a decline in PaO2 and a rise of PaCO2. Infusion of L-NMMA neither affected the fall in PaO2 nor the increase in PaCO2. In contrast, inhalation with NO gas alone as well as the combined administration of L-NMMA infusion and NO-inhalation completely prevented the fall in Pao2 and significantly protected against the increase in Paco2.5. Infusion of endotoxin for 180 min resulted in a mortality of 58%, which was not affected by L-NMMA (63%). In contrast, treatment of LPS-animals with either NO-inhalation alone or NO inhalation plus L-NMMA completely prevented mortality.6. This investigation demonstrates that treatment with NO-inhalation, in order to prevent the dramatic increase in MPAP, PVR and the alterations in peripheral blood gases combined with systemic L-NMMAto improve systemic MABP and thus organ perfusion, may be a new therapeutic regimen in the treatment of septic shock. |
| | |
Authors:
|
P Klemm; C Thiemermann; G Winklmaier; P A Martorana; R Henning |
Related Documents
:
|
16516485 - Inhibition of brain nitric oxide synthesis enhances and prolongs the hypertensive effec... 19468715 - Low level and sub-chronic exposure to methylmercury induces hypertension in rats: nitri... 11124145 - Hemodynamic and renal effects of acute and progressive nitric oxide synthesis inhibitio... 4458775 - Some observations on nitrous oxide cylinders during emptying. 8198945 - Experimental study of determinants of aneurysmal expansion of the abdominal aorta. 17272195 - Continuous blood pressure monitoring utilizing a cmos tactile sensor. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: British journal of pharmacology Volume: 114 ISSN: 0007-1188 ISO Abbreviation: Br. J. Pharmacol. Publication Date: 1995 Jan |
Date Detail:
|
Created Date: 1995-04-10 Completed Date: 1995-04-10 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 7502536 Medline TA: Br J Pharmacol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 363-8 Citation Subset: IM |
Affiliation:
|
SBU Cardiovascular Agents, CASSELLA AG, Frankfurt am Main, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Inhalation Amino Acid Oxidoreductases / antagonists & inhibitors* Animals Arginine / analogs & derivatives, pharmacology Blood Gas Analysis Escherichia coli Hemodynamics / drug effects Hydrogen-Ion Concentration Leukocyte Count Lipopolysaccharides Male Nitrates / blood Nitric Oxide / antagonists & inhibitors, pharmacology* Nitric Oxide Synthase Nitrites / blood Platelet Count Shock, Septic / physiopathology* Swine Tumor Necrosis Factor-alpha / metabolism omega-N-Methylarginine |
| Chemical | |
Reg. No./Substance:
|
0/Lipopolysaccharides; 0/Nitrates; 0/Nitrites; 0/Tumor Necrosis Factor-alpha; 10102-43-9/Nitric Oxide; 17035-90-4/omega-N-Methylarginine; 74-79-3/Arginine; EC 1.14.13.39/Nitric Oxide Synthase; EC 1.4.-/Amino Acid Oxidoreductases |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Modulation by nitric oxide of prostaglandin biosynthesis in the rat.
Next Document: Mechanism of activation of nonselective cation channels by putative M4 muscarinic receptor in guinea...